Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)
Clinical trial NCT03363841 · COMPLETED
Trial details
- NCT number
- NCT03363841
- Sponsor
- Scynexis, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2023-04-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.